We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Tomatoes in Diet Protect Mice from Skin Cancer

By LabMedica International staff writers
Posted on 31 Jul 2017
Print article
Image: Lycopene, the antioxidant red pigment that colors tomatoes (Photo courtesy of Wikimedia Commons).
Image: Lycopene, the antioxidant red pigment that colors tomatoes (Photo courtesy of Wikimedia Commons).
Cancer researchers working with a mouse model showed that a diet supplemented with tomatoes could protect against skin cancer.

Based on previous studies that had found that prolonged tomato consumption could mitigate ultraviolet (UV) light induced sunburn via unknown mechanisms, investigators at Ohio State University (Columbus, USA) hypothesized that tomato consumption would protect against skin cancer.

To test this theory, the investigators fed diets supplemented with 10% tangerine or red tomato powder to a population of SKH-1 hairless and immunocompetent mice for 35 weeks. From weeks 11 to 20, the mice were exposed to UV light, three times per week, and tumors were tracked weekly. Control mice were fed the same diets but not exposed to UV light.

Results published in the July 11, 2017, online edition of the journal Scientific Reports revealed that significantly fewer tumors developed in male mice consuming red tomato diets or pooled tomato diets compared to controls. Carotenoid levels in plasma and skin were quantitated, with total lycopene higher in skin of tangerine fed animals despite a lower dose. Lycopene, the primary carotenoid in tomatoes, has been shown to be the most effective antioxidant of these pigments.

Metabolomic analyses elucidated compounds derived from tomato glycoalkaloids (including tomatidine and hydroxylated-tomatidine) as significantly different metabolites in skin after tomato supplementation.

Results showing that there were no significant differences in tumor number for female mice in the study confirmed previous findings that male mice developed tumors earlier after UV exposure and that their tumors are more numerous, larger, and more aggressive.

"This study showed us that we do need to consider sex when exploring different preventive strategies," said senior author Dr. Tatiana Oberyszyn, professor of pathology at Ohio State University. "What works in men may not always work equally well in women and vice versa."

Related Links:
Ohio State University

New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Unstirred Waterbath
HumAqua 5
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.